ketoconazole has been researched along with Nausea in 5 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The pharmacology, in vitro mycologic activity, toxicity, and efficacy of ketoconazole were studied in a Phase-II evaluation by the National Institutes of Health and National Institute of Allergy and Infectious Disease Mycoses Study Group." | 7.66 | Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. ( Bowles, C; Cloud, G; Craven, PC; Dismukes, WE; Fields, BT; Gallis, HA; Graybill, JR; Gregg, CR; Kaplowitz, LG; Kerkering, TA; Marier, RL; Medoff, G; Sarosi, GA; Shadomy, S; Stamm, AM; Stevens, DA; Stiller, RL, 1983) |
| " Because ketoconazole has in-vitro activity against Blastomyces dermatitidis, we administered this agent in a dosage of 400 mg/d to 46 patients with blastomycosis, with 43 patients receiving at least 1 month of therapy." | 5.27 | Ketoconazole therapy for endemic blastomycosis. ( Abernathy, RS; Bradsher, RW; Rice, DC, 1985) |
| "The pharmacology, in vitro mycologic activity, toxicity, and efficacy of ketoconazole were studied in a Phase-II evaluation by the National Institutes of Health and National Institute of Allergy and Infectious Disease Mycoses Study Group." | 3.66 | Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study. ( Bowles, C; Cloud, G; Craven, PC; Dismukes, WE; Fields, BT; Gallis, HA; Graybill, JR; Gregg, CR; Kaplowitz, LG; Kerkering, TA; Marier, RL; Medoff, G; Sarosi, GA; Shadomy, S; Stamm, AM; Stevens, DA; Stiller, RL, 1983) |
| " Because ketoconazole has in-vitro activity against Blastomyces dermatitidis, we administered this agent in a dosage of 400 mg/d to 46 patients with blastomycosis, with 43 patients receiving at least 1 month of therapy." | 1.27 | Ketoconazole therapy for endemic blastomycosis. ( Abernathy, RS; Bradsher, RW; Rice, DC, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dismukes, WE | 2 |
| Stamm, AM | 2 |
| Graybill, JR | 1 |
| Craven, PC | 1 |
| Stevens, DA | 1 |
| Stiller, RL | 1 |
| Sarosi, GA | 1 |
| Medoff, G | 1 |
| Gregg, CR | 1 |
| Gallis, HA | 1 |
| Fields, BT | 1 |
| Marier, RL | 1 |
| Kerkering, TA | 1 |
| Kaplowitz, LG | 1 |
| Cloud, G | 1 |
| Bowles, C | 1 |
| Shadomy, S | 1 |
| Pont, A | 1 |
| Bradsher, RW | 1 |
| Rice, DC | 1 |
| Abernathy, RS | 1 |
1 review available for ketoconazole and Nausea
| Article | Year |
|---|---|
Current therapy of pulmonary and disseminated fungal diseases.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Chromoblastomycosis; C | 1983 |
1 trial available for ketoconazole and Nausea
| Article | Year |
|---|---|
Long-term experience with high dose ketoconazole therapy in patients with stage D2 prostatic carcinoma.
Topics: Aged; Aged, 80 and over; Clinical Trials as Topic; Humans; Ketoconazole; Male; Middle Aged; Nausea; | 1987 |
3 other studies available for ketoconazole and Nausea
| Article | Year |
|---|---|
Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. National Institute of Allergy and Infectious Diseases collaborative antifungal study.
Topics: Adolescent; Adult; Aged; Anorexia; Antifungal Agents; Child; Child, Preschool; Drug Evaluation; Huma | 1983 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidom | 1997 |
Ketoconazole therapy for endemic blastomycosis.
Topics: Adult; Aged; Blastomycosis; Endocrine System Diseases; Female; Humans; Ketoconazole; Lung Diseases, | 1985 |